Qualidade de vida de asmáticos graves submetidos à intervenção de telemedicina

Abstract

Asthma is one of the most prevalent chronic diseases globally, affecting approximately 339 million people worldwide. Additionally, it ranks 28th among the main causes of disability due to illness and 16th among the main causes of years lived with disability. The absence of asthma control is the main risk factor related to death, the main causes of which are respiratory failure and asthma attacks. In general, the reduction in the quality of life of asthmatics is proportional to the degree of activity of the disease, and asthma is a disease that can cause considerable

physical, emotional and social restrictions to asthmatics, when not controlled. This is a quasi- experimental study carried out in a reference center for the treatment of severe asthma, where

a convenience sample of 67 individuals in the intervention group was analyzed. For the sociodemographic and clinical characterization in V0 and V1, the nonparametric variables, verified by means of the Kolmogorov-Smirnov test, with statistically significant results with p <0.05. In the comparison between V0 and VI, the quality of life scores were maintained (V0: QOL = 4.53 [1.53 - 7.00] vs. V1: QOL = 4.20 [1.93 - 7.00], P = 0.41). The highest scores were in the symptom domains (V0: QOL = Md: 5.20 [1.00 - 7.00] vs. V1: QL = Md: 4.80 [1.20 - 7.00], P = 0, 75) and the lowest scores in the environmental stimulus domain (V0: QV = Md: 3.66 [1.00 - 7.00] vs. V1: QV = Md: 3.33 [1.00 - 7.00], P = 0.77). In the studies carried out, we identified that the severe asthmatics participants had a moderate loss of quality of life, with maintenance after the intervention. The study contributed mainly to rethink how the telemedicine tool can be an alternative for improving asthma management for the population and health professionals.